Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing
Ilaria Bertocchi, Federica Foglietta, Debora Collotta, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4921-4930
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
Jianxiong Zeng, Xiaochun Xie, Xiaoli Feng, et al.
EBioMedicine (2021) Vol. 75, pp. 103803-103803
Open Access | Times Cited: 112
COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review
Tissa Wijeratne, Sheila G. Crewther, Carmela Sales, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 66
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection
Maedeh Vahabi, Tooba Ghazanfari, Saeed Sepehrnia
International Immunopharmacology (2022) Vol. 112, pp. 109183-109183
Open Access | Times Cited: 43
COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Mohammad Bahadoram, et al.
Basic & Clinical Pharmacology & Toxicology (2020) Vol. 128, Iss. 1, pp. 37-45
Open Access | Times Cited: 52
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 17
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Roohangiz Nashibi, et al.
Immunopharmacology and Immunotoxicology (2021) Vol. 43, Iss. 3, pp. 247-258
Open Access | Times Cited: 32
Possible mechanisms of cholesterol elevation aggravating COVID-19
Yan Tang, Longtai Hu, Yi Liu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 15, pp. 3533-3543
Open Access | Times Cited: 31
COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis, et al.
Obesity Research & Clinical Practice (2021) Vol. 15, Iss. 6, pp. 523-535
Open Access | Times Cited: 29
Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome
Liang Yin, Haoxin Zhao, Huiyu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
Mohammad Islamuddin, Salman Ahmad Mustfa, Shehla Nasar Mir Najib Ullah, et al.
Inflammation (2022) Vol. 45, Iss. 5, pp. 1849-1863
Open Access | Times Cited: 21
Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
Ali Saeedi‐Boroujeni, Roohangiz Nashibi, Ata Ghadiri, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 4, pp. 368-377
Open Access | Times Cited: 20
Obesity and Its Impact on Adverse In-Hospital Outcomes in Hospitalized Patients With COVID-19
Karsten Keller, Ingo Sagoschen, Volker H. Schmitt, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
Dongling Liu, Xiang Zeng, Zufeng Ding, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials
Chia Siang Kow, Learn‐Han Lee, Dinesh Sangarran Ramachandram, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 2, pp. 255-264
Open Access | Times Cited: 24
COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study
Raíssa Campos D’Amico, Seigo Nagashima, Lucas Baena Carstens, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1541-1541
Open Access
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
Yuan-Yuan Yong, Li Zhang, Yu-Jiao Hu, et al.
Clinical Immunology (2022) Vol. 244, pp. 109093-109093
Open Access | Times Cited: 14
PM2.5 exposure inducing ATP alteration links with NLRP3 inflammasome activation
Xiang Zeng, Dongling Liu, Weidong Wu, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 17, pp. 24445-24456
Open Access | Times Cited: 12
Shared Inflammatory Pathology of Stroke and COVID-19
Kathryn E. Sánchez, Gary A. Rosenberg
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5150-5150
Open Access | Times Cited: 12
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19
Danielle E. Brain, Alexander J. Plant-Hately, Bethany J. Heaton, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113848-113848
Open Access | Times Cited: 12
COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications
Mohammad Bahadoram, Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 1
Open Access | Times Cited: 9
Obesity and coronavirus disease 2019
Sijia Fei, Xinyuan Feng, Jingyi Luo, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 3, pp. 207-218
Open Access | Times Cited: 7
Alcohol use disorder as a potential risk factor forCOVID‐19 severity: A narrative review
Christopher B. Forsyth, Robin M. Voigt, Garth Swanson, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 11, pp. 1930-1943
Open Access | Times Cited: 7
Ischemic stroke and COVID-19 infection — a review of clinical case reports
Mahant Malempati, Milee Patel, Jyoti K. Patel
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Vaccines and drugs under clinical trials for prevention and treatment of COVID-19
Umesh C. S. Yadav
VirusDisease (2021) Vol. 32, Iss. 1, pp. 13-19
Open Access | Times Cited: 7
The NLRP3-Inflammasome in Health and Disease
Anna Perri
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13103-13103
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top